scholarly journals Therapeutic activity of DCC‐2036, a novel tyrosine kinase inhibitor, against triple‐negative breast cancer patient‐derived xenografts by targeting AXL/MET

2018 ◽  
Vol 144 (3) ◽  
pp. 651-664 ◽  
Author(s):  
Yingying Shen ◽  
Wei Zhang ◽  
Jianghua Liu ◽  
Jun He ◽  
Renxian Cao ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patient ◽  
Tyrosine Kinase ◽  
Breast Cancer Patient ◽  
Tyrosine Kinase Inhibitor ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Kinase Inhibitor ◽  
Therapeutic Activity

scholarly journals Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and Metastasis

2016 ◽  
Vol 23 (11) ◽  
pp. 2806-2816 ◽  
Author(s):  
Wilhem Leconet ◽  
Myriam Chentouf ◽  
Stanislas du Manoir ◽  
Clément Chevalier ◽  
Audrey Sirvent ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patient ◽  
Breast Cancer Patient ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Therapeutic Activity

scholarly journals Pan-TAM Tyrosine Kinase Inhibitor BMS-777607 Enhances Anti–PD-1 mAb Efficacy in a Murine Model of Triple-Negative Breast Cancer

2019 ◽  
Vol 79 (10) ◽  
pp. 2669-2683 ◽  
Author(s):  
Canan Kasikara ◽  
Viralkumar Davra ◽  
David Calianese ◽  
Ke Geng ◽  
Thomas E. Spires ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Triple Negative Breast Cancer ◽  
Murine Model ◽  
Triple Negative ◽  
Kinase Inhibitor
Sign in / Sign up

Export Citation Format

Share Document